M. Härter

Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor

P. Kolkhof, A. Geerts, F. Wunder, 2010, British journal of pharmacology.

Nitric Oxide-independent Activation of Soluble Guanylate Cyclase by BAY 60-2770 in Experimental Liver Fibrosis

J. Stasch, F. Wunder, C. Alonso-Alija, 2008, Arzneimittel-Forschung (Drug Research).

Nitric Oxide-independent Activation of Soluble Guanylate Cyclase by BAY 60-2770 in Experimental Liver Fibrosis

J. Stasch, F. Wunder, A. Knorr, 2008, Arzneimittel-Forschung (Drug Research).